Difference between revisions of "Heddleston JM, et al. Cell Cycle (2009) cited as Ref 444 in DOI: 10.1038/s41392-020-0110-5 (Q9707)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): 3274-3284, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fifth Author string (P153): Rich JN, #quickstatements; #temporary_batch_1590155508986) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / Fourth Author string | |||
| + | Hjelmeland AB | ||
| Property / Fourth Author string: Hjelmeland AB / rank | |||
| + | Normal rank | ||
| Property / Fifth Author string | |||
| + | Rich JN | ||
| Property / Fifth Author string: Rich JN / rank | |||
| + | Normal rank | ||
Latest revision as of 13:52, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Heddleston JM, et al. Cell Cycle (2009) cited as Ref 444 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Heddleston JM
0 references
Li Z
0 references
McLendon RE
0 references
2009
0 references
Cell Cycle
0 references
8
0 references
The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype (English)
0 references
3274-3284
0 references
Hjelmeland AB
0 references
Rich JN
0 references
